La gestione della terapia ipoglicemizzante nel paziente con nefropatia da diabete mellito tipo 2
Chronic kidney disease (CKD) is constantly increasing in terms of prevalence and incidence. Subjects with impaired renal function, even if only in the presence of micro/macroalbuminuria, have an increased cardiovascular risk profile. Therefore, we must pay particular attention to the treatment of al...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Italian |
| Published: |
AboutScience Srl
2019-07-01
|
| Series: | Giornale di Clinica Nefrologia e Dialisi |
| Online Access: | https://journals.aboutscience.eu/index.php/gcnd/article/view/527 |
| _version_ | 1828951641908314112 |
|---|---|
| author | Francesco Manetti |
| author_facet | Francesco Manetti |
| author_sort | Francesco Manetti |
| collection | DOAJ |
| description | Chronic kidney disease (CKD) is constantly increasing in terms of prevalence and incidence. Subjects with impaired renal function, even if only in the presence of micro/macroalbuminuria, have an increased cardiovascular risk profile. Therefore, we must pay particular attention to the treatment of all associated risk factors. Therapy with oral hypoglycemic agents often requires modulation of drug dosage based on kidney function. Today, there are molecules available that are able not only to induce cardiovascular protection, but also to slow the progression of renal damage. |
| first_indexed | 2024-12-14T06:40:45Z |
| format | Article |
| id | doaj.art-29fb24277b5949c38d627318ae4135f8 |
| institution | Directory Open Access Journal |
| issn | 2705-0076 |
| language | Italian |
| last_indexed | 2024-12-14T06:40:45Z |
| publishDate | 2019-07-01 |
| publisher | AboutScience Srl |
| record_format | Article |
| series | Giornale di Clinica Nefrologia e Dialisi |
| spelling | doaj.art-29fb24277b5949c38d627318ae4135f82022-12-21T23:13:13ZitaAboutScience SrlGiornale di Clinica Nefrologia e Dialisi2705-00762019-07-0131310.33393/gcnd.2019.527La gestione della terapia ipoglicemizzante nel paziente con nefropatia da diabete mellito tipo 2Francesco ManettiChronic kidney disease (CKD) is constantly increasing in terms of prevalence and incidence. Subjects with impaired renal function, even if only in the presence of micro/macroalbuminuria, have an increased cardiovascular risk profile. Therefore, we must pay particular attention to the treatment of all associated risk factors. Therapy with oral hypoglycemic agents often requires modulation of drug dosage based on kidney function. Today, there are molecules available that are able not only to induce cardiovascular protection, but also to slow the progression of renal damage.https://journals.aboutscience.eu/index.php/gcnd/article/view/527 |
| spellingShingle | Francesco Manetti La gestione della terapia ipoglicemizzante nel paziente con nefropatia da diabete mellito tipo 2 Giornale di Clinica Nefrologia e Dialisi |
| title | La gestione della terapia ipoglicemizzante nel paziente con nefropatia da diabete mellito tipo 2 |
| title_full | La gestione della terapia ipoglicemizzante nel paziente con nefropatia da diabete mellito tipo 2 |
| title_fullStr | La gestione della terapia ipoglicemizzante nel paziente con nefropatia da diabete mellito tipo 2 |
| title_full_unstemmed | La gestione della terapia ipoglicemizzante nel paziente con nefropatia da diabete mellito tipo 2 |
| title_short | La gestione della terapia ipoglicemizzante nel paziente con nefropatia da diabete mellito tipo 2 |
| title_sort | la gestione della terapia ipoglicemizzante nel paziente con nefropatia da diabete mellito tipo 2 |
| url | https://journals.aboutscience.eu/index.php/gcnd/article/view/527 |
| work_keys_str_mv | AT francescomanetti lagestionedellaterapiaipoglicemizzantenelpazienteconnefropatiadadiabetemellitotipo2 |